David Rescott
Stock Analyst at Baird
(2.28)
# 1,492
Out of 4,479 analysts
41
Total ratings
44.74%
Success rate
-2.43%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Initiates: Outperform | $96 | $86.50 | +10.98% | 1 | Jun 28, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $79 → $84 | $76.55 | +9.73% | 3 | Apr 25, 2024 | |
| PEN Penumbra | Maintains: Buy | $300 → $290 | $175.99 | +64.78% | 13 | Feb 23, 2024 | |
| AXNX Axonics | Downgrades: Hold | $73 → $71 | $67.45 | +5.26% | 8 | Jan 16, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $115 → $133 | $98.61 | +34.87% | 6 | Dec 22, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $13.00 | +100.00% | 6 | Dec 22, 2023 | |
| LIVN LivaNova | Maintains: Outperform | $56 → $62 | $52.89 | +17.22% | 1 | Jul 27, 2023 | |
| EW Edwards Lifesciences | Initiates: Outperform | $107 | $91.23 | +17.29% | 1 | Jul 19, 2023 | |
| MDT Medtronic | Initiates: Neutral | $90 | $77.37 | +16.32% | 1 | Jul 19, 2023 | |
| NARI Inari Medical | Initiates: Outperform | $79 | $49.80 | +58.63% | 1 | Jul 19, 2023 |
Merit Medical Systems
Jun 28, 2024
Initiates: Outperform
Price Target: $96
Current: $86.50
Upside: +10.98%
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $79 → $84
Current: $76.55
Upside: +9.73%
Penumbra
Feb 23, 2024
Maintains: Buy
Price Target: $300 → $290
Current: $175.99
Upside: +64.78%
Axonics
Jan 16, 2024
Downgrades: Hold
Price Target: $73 → $71
Current: $67.45
Upside: +5.26%
iRhythm Technologies
Dec 22, 2023
Maintains: Buy
Price Target: $115 → $133
Current: $98.61
Upside: +34.87%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $13.00
Upside: +100.00%
LivaNova
Jul 27, 2023
Maintains: Outperform
Price Target: $56 → $62
Current: $52.89
Upside: +17.22%
Edwards Lifesciences
Jul 19, 2023
Initiates: Outperform
Price Target: $107
Current: $91.23
Upside: +17.29%
Medtronic
Jul 19, 2023
Initiates: Neutral
Price Target: $90
Current: $77.37
Upside: +16.32%
Inari Medical
Jul 19, 2023
Initiates: Outperform
Price Target: $79
Current: $49.80
Upside: +58.63%